Abstract:Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations. We developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R 2 ) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5×10 −6 and 5×10 −7 , the prediction models for FNK-BMD and SPN-BMD achieved the highest R 2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population ( P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors. In this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5×10 −6 or 5×10 −7 ) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.

Association of distal radial fracture with comorbidities: model development and validation

Clinical Value of Machine Learning Models in Early Osteoporosis Prediction Based on Demographic and Routine Biochemical Indicators

A Novel Fracture Prediction Model Using Machine Learning in a Community‐Based Cohort

Fracture risk prediction in postmenopausal women with traditional and machine learning models in a nationwide, prospective cohort study in Switzerland with validation in the UK Biobank

Predicting fractures in an international cohort using risk factor algorithms without BMD

Machine Learning to Predict Long and Short Term Fracture Risk in Postmenopausal Women

Predicting Osteoporotic Fracture in Patients with Early-Stage Diabetic Kidney Disease Using a Radiomic Model: A Longitudinal Cohort Study

Fragility Fractures in Postmenopausal Women: Development of 5-Year Prediction Models Using the FRISBEE Study

Improving the Hip Fracture Risk Prediction Through 2D Finite Element Models From DXA Images: Validation Against 3D Models

Prediction models incorporating second metacarpal cortical index for osteoporosis in rheumatoid arthritis: Externally validated machine learning models developed using data from the KURAMA cohort

A novel clinical prediction model for hip fractures: a development and validation study in the total population of Sweden

Building a predictive model for depression risk in fracture patients: insights from cross-sectional NHANES 2005-2020 data and an external hospital-based dataset

Incident Fractures of the Distal Radius: Dual-Energy CT-derived Metrics For Opportunistic Risk Stratification

Variability in performance of genetic-enhanced DXA-BMD prediction models across diverse ethnic and geographic populations: A risk prediction study

Development of prediction model for osteoporotic vertebral compression fracture screening without using clinical risk factors, compared with FRAX and other previous models

Developing Novel Prognostic Biomarkers for Multivariate Fracture Risk Prediction Algorithms

Proximal Humeral Bone Density Assessment and Prediction Analysis Using Machine Learning Techniques: an Innovative Approach in Medical Research

Predicting fracture risk for elderly osteoporosis patients by hybrid machine learning model

Predictors of fracture in middle-aged and older adults with type 2 diabetes and overweight or obesity

3D Analysis of the Proximal Femur Compared to 2D Analysis for Hip Fracture Risk Prediction in a Clinical Population

Hip Fracture Risk Assessment in Elderly and Diabetic Patients: Combining Autonomous Finite Element Analysis and Machine Learning